Companies / United Kingdom
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
AstraZeneca Agrees Deal With BMS Over Diabetes Candidates
January 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Anglo-Swedish drugmaker AstraZeneca has struck a deal to partner two diabetes drugs developed by US-based Bristol-Myers Squibb (BMS). The agreement involves an initial down payment of US$100mn that could eventually rise to US$1bn if certain milestones and sales are met.